Vir Biotechnology has officially entered into a global strategic collaboration with Astellas Pharma. The agreement focuses on the co-development and... Read more
Category: Uncategorized
Terremoto secures $108M in Series C to advance next-generation AKT inhibitor programs
Terremoto Biosciences has successfully closed a $108 million Series C financing round. The capital will be utilized to push its... Read more
Roche to launch new trial for Elevidys following European regulatory setback
Swiss drugmaker Roche has announced plans to initiate a new global Phase 3 clinical trial for Elevidys. This move is... Read more
Former Deputy Surgeon General nominated as next CDC Director
On April 16, President Trump tapped Erica Schwartz to lead the Centers for Disease Control and Prevention (CDC). If confirmed... Read more
Kailera nets $625M in one of the biotech sector’s largest-ever IPOs
On April 16, Kailera Therapeutics, an obesity drug developer, announced it had raised $625 million in its initial public offering... Read more
Eli Lilly releases updated safety data for Foundayo following FDA request
Following the recent approval of Foundayo (orforglipron), the U.S. Food and Drug Administration (FDA) is mandating a series of post-approval... Read more
Roche to launch new trial following EU rejection of Duchenne gene therapy
The Swiss pharmaceutical giant Roche has announced the launch of a new global Phase 3 clinical trial for Elevidys. This... Read more
Viatris and Teva launch product recalls over manufacturing and material issues
The U.S. Food and Drug Administration (FDA) has recently announced separate recalls initiated by Viatris and Teva Pharmaceutical Industries. Both... Read more
Ministry of Health evaluates the centralized food management model in Ho Chi Minh City
During a field supervision visit on April 16, leaders of the Ministry of Health provided key assessments regarding the effectiveness... Read more









